Dr. Gebeyehu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Medical Center Blvd
Winston Salem, NC 27157Phone+1 404-265-4919- Is this information wrong?
Summary
- Dr. Rediet Gebeyehu is a Clinical Fellow in Hematology Oncology at Atrium Health WakeForest Baptist. She completed her Hospice Palliative care Fellowship and Internal Medicine Residency Program at Wellstar Health System in Atlanta,GA.
Education & Training
- Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 2021 - 2024
- Wellstar Health System/Wellstar Atlanta Medical CenterFellowship, Hospice and Palliative Medicine, 2020 - 2021
- Wellstar Health System/Wellstar Atlanta Medical CenterResidency, Internal Medicine, 2014 - 2017
- Addis Ababa University Faculty of MedicineClass of 2010
Certifications & Licensure
- NC State Medical License 2021 - 2025
- GA State Medical License 2017 - 2022
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition Start of enrollment: 2021 Feb 25
Publications & Presentations
PubMed
- Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell ca...Burcher, K., Bloomer, C., Gavrila, E., Kalada, J., Chang, M., Gebeyehu, R., Song, A., Khoury, L., Lycan, T., Kinney, R., D'Agostino, R., Bunch, P., Shukla, K., Triozzi...> ;Therapeutic Advances in Medical Oncology. 2024 Jan 1
- 1 citationsQuad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer.Ryan T Hughes, Rediet R Gebeyehu, John Mason Kalada, Thomas W Lycan, Bart A Frizzell, Rebecca D Kinney, Ralph B D'Agostino, Paul M Bunch, Pierre Triozzi, Wei Zhang, Cr...> ;Future Oncology. 2023 Jul 1
- 1 citationsExceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cance...Chance H Bloomer, Elena Gavrila, Kimberly M Burcher, John M Kalada, Mark J Chang, Rediet R Gebeyehu, Elsabeth Asare, Lara M Khoury, Rebecca Kinney, Bart Frizzell, Chri...> ;Therapeutic Advances in Medical Oncology. 2023 Jan 1
- Join now to see all
Abstracts/Posters
- Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell ca...Kimberly M Burcher 1, Chance H Bloomer 1, Elena Gavrila 2, John M Kalada 1, Mark J Chang 1, Rediet R Gebeyehu 3, Alexander H Song 3, Lara M Khoury 1, Thomas W Lycan 3 ..., Therapeutic advances in medical Oncology
- UTILIZATION OF 4T PRETEST PROBABILITY SCORING SYSTEM IN HEPARIN-INDUCED THROMBOCYTOPENIA AT WELLSTAR ATLANTA MEDICAL CENTER: A QUALITY IMPROVEMENT STUDYRediet Gebeyehu, Aderajew Tadesse, Getnet Tioum, Douglass Collins and Admasu Taddesse Wellstar Atlanta Medical Center, Atlanta, GA, U.S.A., ABSTRACTS OF THE 7TH INTERNATIONAL CONFERENCE ON ADVANCES IN HEMATOLOGY AND ONCOLOGY (ICAHO2019), 29-30 June, 2019, Issaquah, WA, USA, 6/29/2019
- The Path to Recovery from Malignant Status EpilepticusJobira Woldemichael, MD; Atlanta Medical Center, Atlanta, GA Ngozika Orjioke, MD, FCCP; Atlanta Medical Center, Atlanta, GA Eltrimizi Mohammed, MD; Atlanta Medical Cen..., 16th Annual Southern Hospital Medicine Conference Abstracts, Ochsner J. 2016 Spring; 16(1): e1–e42, 2016
- Join now to see all
Hospital Affiliations
- WellStar Cobb HospitalAustell, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: